The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of real-time serial comprehensive tumor analytics: Pilot study of olaparib and durvalumab in metastatic triple negative breast cancer (mTNBC).
 
Allen Li
No Relationships to Disclose
 
Marilyne Labrie
No Relationships to Disclose
 
Jacqueline Vuky
Consulting or Advisory Role - Seattle Genetics/Astellas
Research Funding - Celldex (Inst); Fortis (Inst); Innocrin Pharma (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Jeong Youn Lim
No Relationships to Disclose
 
Brett Johnson
No Relationships to Disclose
 
Sam Sivagnanam
No Relationships to Disclose
 
Courtney Betts
No Relationships to Disclose
 
Lisa Coussens
Consulting or Advisory Role - Carisma Therapeutics; Cell Signaling Technologies; CytomX Therapeutics; Pharmacyclics; Syndax; Verseau Therapeutics; Zymeworks
Research Funding - Cell Signaling Technologies; Innate Pharma; Pharmacyclics; Prospect Creek Foundation; Syndax
Travel, Accommodations, Expenses - AstraZeneca; Carisma Therapeutics; Cell Signaling Technologies; CytomX Therapeutics; Pharmacyclics; Verseau Therapeutics
 
Christopher L. Corless
Employment - Omics Data Automation
Leadership - Omics Data Automation
Stock and Other Ownership Interests - Guardant Health; Omics Data Automation
Honoraria - Roche
Consulting or Advisory Role - Roche; Thermofisher Scientific Biomarkers
Research Funding - Aileron Therapeutics
Travel, Accommodations, Expenses - Cepheid; Roche; Thermo Fisher Scientific
 
Raymond C. Bergan
Stock and Other Ownership Interests - Third Coast Therapeutics
Patents, Royalties, Other Intellectual Property - I hold several patents, and currently have two pending, related to small molecule therapeutics that inhibit cancer cell motility, bone destruction and screening assays for potentially active drugs.
(OPTIONAL) Uncompensated Relationships - Hebei Provence Scientific Foundation
 
Joe W. Gray
Leadership - Convergent Genomics; PDX Pharmacy
Stock and Other Ownership Interests - Abbott Diagnostics; AbbVie; Agilent; Alphabet; Altaba; Amazon; American Airlines; Amgen; ANI Pharmaceuticals; Apple; AT&T; Becton Dickinson; Berkshire Hathaway; Boston Scientific; Cameco; Chevron; Cisco Systems; Cisco Systems; Clorox Company; ConocoPhillips; Devon Energy; Exxon Mobil; Facebook; First Solar; Freeport McMoRan; General Electric; Gilead Sciences; Google; Heineken; Hewlett-Packard; IBM; Intel; Ions Pharmaceuticals; Jet Blue Airlines; Johnson & Johnson; Medtronic; Microsoft; Navidea; OncoMed; Pepsico; Philips Healthcare; Procter & Gamble; Southwest Airlines; Stryker; SunPower; Swiss Helvetia Fund; The Walt Disney Company; Unilever; Walgreens Boots Alliance; Wells Fargo; Yum! Brands; Zimmer BioMet
Consulting or Advisory Role - Colorado School of Mines; MJ Murdock Charitable Trust; New Leaf Venture; Radiation Effects Research Foundation; Susan G. Komen for the Cure; University of Colorado Denver; University of Minnesota; University of New Mexico Comprehensive Cancer Center
Research Funding - Danaher; Micron; Miltenyi Biotec; PDX Pharmacy; Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - Abbott; Cepheid
Travel, Accommodations, Expenses - Miltenyi Biotec; Radiation Effects Research Foundation
 
Gordon B. Mills
Stock and Other Ownership Interests - Catena; ImmunoMET; SignalChem; Spindletop Ventures; Tarveda Therapeutics
Honoraria - AstraZeneca; ImmunoMET; Lilly; Nuevolution; PDX Pharmacy; Symphogen; Tarveda Therapeutics; Tesaro
Consulting or Advisory Role - AstraZeneca; ImmunoMET; Lilly; PDX Pharmacy; SignalChem; Symphogen; Takeda/Millennium; Tarveda Therapeutics
Research Funding - Adelson Medical Research Foundation; AstraZeneca; Breast Cancer Research Foundation; ImmunoMET; Ions Pharmaceuticals; Karus Therapeutics; NanoString Technologies; Pfizer; Prospect Creek Foundation; Tarveda Therapeutics
Patents, Royalties, Other Intellectual Property - DSP technology patent with Nanostring; HRD assay to Myriad Genetics
Travel, Accommodations, Expenses - AstraZeneca; Chrysalis Biomedical Advisors; ImmunoMET; Michigan Primary Care Consortium; Pfizer; Symphogen
 
Zahi Ibrahim Mitri
Consulting or Advisory Role - Lilly; Pfizer/EMD Serono; Puma Biotechnology; Samsung Bioepis
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Novartis (Inst); Radius Health (Inst); Seagen (Inst)